Herantis Pharma Oyj Stock Filter Stocks by Fundamentals
HRTIS Stock | EUR 1.49 0.07 4.49% |
Herantis Pharma Oyj fundamentals help investors to digest information that contributes to Herantis Pharma's financial success or failures. It also enables traders to predict the movement of Herantis Stock. The fundamental analysis module provides a way to measure Herantis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Herantis Pharma stock.
Herantis |
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
Herantis Fundamentals
Return On Equity | -13.37 | |||
Return On Asset | -0.6 | |||
Current Valuation | 25.86 M | |||
Shares Outstanding | 16.91 M | |||
Shares Owned By Insiders | 31.52 % | |||
Shares Owned By Institutions | 32.60 % | |||
Price To Earning | (7.20) X | |||
Price To Book | 15.17 X | |||
Gross Profit | 90 K | |||
EBITDA | (9.74 M) | |||
Net Income | (12.77 M) | |||
Cash And Equivalents | 7.86 M | |||
Cash Per Share | 0.81 X | |||
Total Debt | 6.29 M | |||
Debt To Equity | 0.95 % | |||
Current Ratio | 1.54 X | |||
Book Value Per Share | 0.11 X | |||
Cash Flow From Operations | (9.93 M) | |||
Earnings Per Share | (1.25) X | |||
Target Price | 2.1 | |||
Number Of Employees | 13 | |||
Beta | 0.51 | |||
Market Capitalization | 39.58 M | |||
Total Asset | 7.76 M | |||
Retained Earnings | (27 M) | |||
Working Capital | 5 M | |||
Current Asset | 6 M | |||
Current Liabilities | 1000 K | |||
Z Score | -3.9 | |||
Net Asset | 7.76 M |
About Herantis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Herantis Pharma Oyj's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Herantis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Herantis Pharma Oyj based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.